Bio-Techne Corp - Common Stock (TECH)
63.00
+0.91 (1.47%)
NASDAQ · Last Trade: Oct 3rd, 3:03 PM EDT
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.
Via StockStory · October 2, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
Via Chartmill · October 2, 2025
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Via StockStory · October 2, 2025
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.
Via Benzinga · October 1, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between pharmaceutical giant Pfizer (NYSE: PFE) and the U.S. government has sparked a "relief rally" for some major players, the broader market remains
Via MarketMinute · September 30, 2025
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE). This surge, echoing similar positive movements for other life sciences companies like
Via MarketMinute · September 30, 2025
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move signaling a broader governmental push to significantly lower prescription drug costs. While such developments typically send ripples across the entire
Via MarketMinute · September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via StockStory · September 30, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH)
jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via StockStory · September 30, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · September 30, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · September 24, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends.
Via Chartmill · September 24, 2025
The financial markets are abuzz following the Federal Reserve's recent decision to cut interest rates, a move widely interpreted as an attempt to inject new vigor into the economy. This policy shift immediately reduces the cost of borrowing for corporations, a critical factor influencing decisions on new investments and hiring.
Via MarketMinute · September 17, 2025
The Federal Reserve has announced a 0.25% reduction in its benchmark interest rate, marking a significant shift towards a more accommodative monetary policy. This move, while seemingly modest, carries profound implications for the financial markets, signalling the central bank's intent to provide economic stimulus amidst evolving global and domestic
Via MarketMinute · September 17, 2025
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.
Via StockStory · September 16, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · September 12, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH)
fell 4.8% in the afternoon session after the company presented a cautious outlook at the Baird Global Healthcare Conference, highlighting significant market challenges despite some areas of growth.
Via StockStory · September 10, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.
Via Chartmill · September 10, 2025
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Via StockStory · September 5, 2025
RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and alignment with sector valuations.
Via Benzinga · September 3, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH)
fell 3.3% in the afternoon session after the major indices continued to retreat (Nasdaq -1.5%, S&P 500 -1.2%) amid profit-taking and renewed concerns about tariffs. The decline was not driven by company-specific news but rather widespread negative sentiment as investors returned from the Labor Day holiday. Major U.S. indexes, including the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite, all tumbled. The downturn was fueled by a mix of factors, including rising Treasury yields and fresh uncertainty after a court decision ruled most of President Trump's tariffs illegal. Although the tariffs remain in place pending appeal, the news contributed to market turbulence on the first trading day of what is historically the stock market's most challenging month.
Via StockStory · September 2, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
Via Chartmill · August 28, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · August 28, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Via StockStory · August 22, 2025